Skip to content

Relay Therapeutics, Inc. RLAY Total Current Assets

Total Current Assets at other companies

Celcuity logo
CelcuityCELC
$408.93M+87.9%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$1.97B-7.8%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$865.42M+180%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$877.8M+247%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$392.33M+74.4%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$763.95M+34.1%

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.46B+300%
Enterprise value$3.29B+304%
P/S324.1×+212×

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s total current assets?
Relay Therapeutics, Inc. (RLAY) reported total current assets of $658.46M in Q1 2026.
How has Relay Therapeutics, Inc.'s total current assets changed year-over-year?
Relay Therapeutics, Inc.'s total current assets decreased by 11.0% year-over-year, from $739.66M to $658.46M.
What is the long-term trend for Relay Therapeutics, Inc.'s total current assets?
Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s total current assets has grown at a -5.6% compound annual growth rate (CAGR), from $770.1M to $578.28M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.